The recent approval of geographic atrophy (GA) therapy in Australia will significantly change the way eyecare providers manage this irreversible disease.
In this educational article, Ms Jennifer Chin, Dr Long Phan and Prof Andrew Chang detail practical considerations and the clinical impacts of these new therapies for patients.
Read now to claim your CPD points
